Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Genzyme Diacrin/Genzyme Corporation LLC |
---|---|
Information provided by: | Genzyme |
ClinicalTrials.gov Identifier: | NCT00226460 |
The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo treatment.
Condition | Intervention | Phase |
---|---|---|
Parkinson's Disease |
Drug: Fetal porcine cells, Neurocell-PD |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 40 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | PD96-1101 |
Study First Received: | September 23, 2005 |
Last Updated: | June 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00226460 |
Health Authority: | United States: Food and Drug Administration |
Ganglion Cysts Movement Disorders Parkinson Disease Basal Ganglia Diseases |
Central Nervous System Diseases Parkinsonian Disorders Neurodegenerative Diseases Brain Diseases |
Nervous System Diseases |